The Bleeding Assessment Tool (BAT)
NCT07560007 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-04-30
Summary
This study looks at whether adding simple family history questions to a standard bleeding questionnaire can better identify children who truly have mild bleeding disorders. Because young children often haven't had major bleeding challenges yet, their own symptoms may not tell the full story, so family history could provide important extra information. By reviewing several years of clinic data, the researchers aim to see if this combined approach helps doctors decide more accurately who needs further testing, especially in children under 8 years old.
Conditions
- Bleeding Disorder
- Von Willebrand Disease (VWD)
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-09
- Primary Completion
- 2026-07-05
- Completion
- 2027-07-05
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
NCT01410227 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age
NCT00759655 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating The Safety Of Xyntha In Usual Care Settings
NCT00765726 ·Status: TERMINATED ·Phase: PHASE4
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Platelet Function in Patients With Hemophilia A
NCT02093065 ·Status: COMPLETED
-
An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
NCT00945906 ·Status: COMPLETED ·Phase: PHASE3
-
Are There Differences Between Carriers of Haemophilia A and B?
NCT05217992 ·Status: COMPLETED
-
Early Genomic Testing for Inherited Bleeding Disorders
NCT06736158 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
NCT02564718 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bleeding Symptoms of Carriers of Hemophilia A and B
NCT01029808 ·Status: COMPLETED
-
UK - EHL Outcomes Registry
NCT02938156 ·Status: UNKNOWN
-
Inhibitor Development in Patients With Hemophilia A Undergoing Surgery
NCT01571934 ·Status: COMPLETED
-
Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)
NCT02466789 ·Status: COMPLETED
-
Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency
NCT01253811 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors
NCT02020369 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia
NCT01439971 ·Status: COMPLETED ·Phase: PHASE1
-
World Bleeding Disorders Registry
NCT03327779 ·Status: RECRUITING
-
Learning to Live With Non-severe Haemophilia
NCT05314751 ·Status: COMPLETED
-
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
NCT00178607 ·Status: COMPLETED
-
The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B
NCT03623295 ·Status: COMPLETED
-
Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia
NCT03299699 ·Status: COMPLETED
-
Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate
NCT07410130 ·Status: NOT_YET_RECRUITING
-
Hemophilia Inhibitor Previously Untreated Patient Study
NCT01652027 ·Status: COMPLETED
-
A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A
NCT02615691 ·Status: COMPLETED ·Phase: PHASE3
-
Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage
NCT00770718 ·Status: TERMINATED ·Phase: PHASE1